Acoramidis
Acoramidis, sold under the brand name Attruby, is a medication used for the treatment of cardiomyopathy.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Acoramidis, sold under the brand name Attruby, is a medication used for the treatment of cardiomyopathy. It is a near-complete (>90%) transthyretin stabilizer, developed to mimic the protective properties of the naturally occurring T119M mutation, to treat transthyretin amyloid cardiomyopathy. It is taken by mouth.
The most common adverse reactions include diarrhea and upper abdominal pain. Acoramidis was approved for medical use in the United States in November 2024, and in the European Union in February 2025.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374844598 under CC BY-SA 4.0; modifications have been made.